Fortrea Holdings (FTRE) Return on Capital Employed (2023 - 2026)
Fortrea Holdings (FTRE) reported Return on Capital Employed of 20.1% for Q1 2026, up 732.0% on a YoY basis from 2.42% in Q1 2025, and up 58.17% quarter-over-quarter from 48.06% in Q4 2025.
Fortrea Holdings (FTRE) Return on Capital Employed (2023 - 2026) Analysis & Trends
Fortrea Holdings has reported Return on Capital Employed for 4 years, with the latest figure at 20.1% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed rose 732.0% year-over-year to 20.1%; the trailing twelve-month figure through Mar 2026 stood at 20.1% (up 732.0% YoY), and the FY2025 full-year result was 39.06%, down 3367.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 20.1%, up from 48.06% in the prior quarter.
- The five-year high for Return on Capital Employed was 1.97% in Q3 2023, with the low at 48.8% in Q3 2025.
- Historically, Return on Capital Employed has averaged 18.31% across 4 years, with a median of 6.06% in 2024.
- Annual changes were most pronounced in 2025 — Return on Capital Employed plunged 4418 bps — and 2026, when it soared 732 bps.
- Fortrea Holdings' Return on Capital Employed stood at 0.9% in 2023, then sank by 771 bps to 6.06% in 2024, then sank by 693 bps to 48.06% in 2025, then jumped by 58 bps to 20.1% in 2026.
- The last three Return on Capital Employed figures came in at 20.1% (Q1 2026), 48.06% (Q4 2025), and 48.8% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 450.31% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 51.73% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -107.40% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -50.43% |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | -20.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.10% |
| Dec 31, 2025 | -48.06% |
| Sep 30, 2025 | -48.80% |
| Jun 30, 2025 | -45.39% |
| Mar 31, 2025 | -27.42% |
| Dec 31, 2024 | -6.06% |
| Sep 30, 2024 | -4.62% |
| Jun 30, 2024 | -3.23% |
| Mar 31, 2024 | -0.56% |
| Dec 31, 2023 | 0.90% |
| Sep 30, 2023 | 1.97% |